Portacaval shunting and hyperammonemia stimulate the uptake of L-[3H] arginine but not of L-[3H] nitroarginine into rat brain synaptosomes

Journal of Neurochemistry

Volumn 68, Issue 1, 1997, Pages 337-343

  Raghavendra Rao, V L ^a   Audet, R M ^a   Butterworth, R F ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Hepatic encephalopathy; Hyperammonemia; L Arginine; Synaptosomes; Transport; Uptake

Indexed keywords

AMMONIA; ARGININE; N(G) NITROARGININE;

AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; HEPATIC ENCEPHALOPATHY; HYPERAMMONEMIA; MALE; NONHUMAN; PORTOCAVAL SHUNT; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031038242     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68010337.x     Document Type: Article

References (41)

1. Albrecht J. and Hilgier W. (1986) Arginine in thioacetamide-induced hepatogenic encephalopathy in rats: activation of enzymes of arginine metabolism to glutamate. Acta Neurol. Scand. 73, 498-501.
2. Albrecht J., Hilgier W., and Rafalowska U. (1990) Activation of arginine metabolism to glutamate in rat brain synaptosomes in thioacetamide-induced hepatic encephalopathy: an adaptive response? J. Neurosci. Res. 25, 125-130.
3. + in activated macrophages. Biochem. Biophys. Res. Commun. 200, 726-731.
4. Bommarius A. S., Makryaleas K., and Drauz K. (1991) An enzymatic route to L-ornithine from L-arginine - activation and stabilization studies on L-arginase. Biochim. Biophys. Acta 50 (Suppl.), S249-S255.
5. Bonkale W. L., Winblad B., Ravid R., and Cowburn R. F. (1995) Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease. Neurosci. Lett. 187, 5-8.
6. Butterworth R. F. (1992) Evidence that hepatic encephalopathy results from a defect of glutamatergic synaptic regulation. Mol. Neuropharmacol. 2, 229-232.
7. Butterworth R. F. (1995) Hepatic encephalopathy. Neurologist 1, 95-104.
8. Butterworth R. F., Lavoie J., Giguere J. F., Layrargues G. P., and Bergeron M. (1987) Cerebral GABA-ergic and glutamatergic function in hepatic encephalopathy. Neurochem. Pathol. 6, 131-144.
9. Butterworth R. F., Le O., Lavoie J., and Szerb J. C. (1991) Effects of portacaval anastomosis on electrically stimulated release of glutamate from rat hippocampal slices. J. Neurochem. 56, 1481-1484.
10. Dodd P. R., Hardy J. A., Oakley A. E., Edwardson J. A., Perry E. K., and Delaunoy J.-P. (1981) A rapid method for preparing synaptosomes: comparison with alternative procedures. Brain Res. 226, 107-118.
11. Geyer O., Almog J., Lupu-Meiri M., Lazar M., and Oron Y. (1995) Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett. 374, 399-402.
12. Hazell A. S. and Norenberg M. D. (1996) Ammonia and manganese increase arginine uptake in cultured astrocytes. (Abstr.) J. Neurochem. 66 (Suppl. 1), S69C.
13. Jessy J., Mans A. M., DeJoseph M. R., and Hawkins R. A. (1990) Hyperammonemia causes many of the changes found after portacaval shunting. Biochem. J. 272, 311-317.
14. Kosenko E., Kaminsky Y., Grau E., Minana M. D., Grisolia S., and Felipo V. (1995) Nitroarginine, an inhibitor of nitric oxide synthetase, attenuated ammonia toxicity and ammonia-induced alterations in brain metabolism. Neurochem. Res. 20, 381-386.
15. Kuiper M. A., Visser J. J., Beggmans P. L., Scheltens P., and Wolters E. C. (1994) Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients. J. Neurol. Sci. 121, 46-49.
16. Lajtha A. and Sershen H. (1974) Substrate specificity of uptake of diamines in mouse brain slices. Arch. Biochem. Biophys. 165, 539-547.
17. Lee S. H. and Fisher B. (1961) Portacaval shunt in the rat. Surgery 50, 668-672.
18. 3H]arginine transport and nitric oxide synthase in rat brain synaptosomes. Neurosci. Lett. 181, 1-4.
19. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Polin phenol reagent. J. Biol. Chem. 193, 265-275.
20. Mans A. M., DeJoseph M. R., and Hawkins R. A. (1994) Metabolic abnormalities and grade of encephalopathy in acute hepatic failure. J. Neurochem. 63, 1829-1838.
21. 3H]-glutamate binding sites in rat brain following portacaval anastomosis. J. Neurochem. 55, 386-390.
22. Regunathan S., Feinstein D. L., Raasch W., and Reis D. J. (1995) Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes. Neuroreport 6, 1897-1900.
23. 3H]nitroarginine binding sites in rat cerebellum. J. Neurochem. 66, 701-709.
24. Rao V. L. R. and Butterworth R. F. (1996b) Regional distribution of binding sites for the nitric oxide synthase inhibitor L-[H]-nitroarginine in rat brain. Neurochem. Res. 21, 355-359.
25. 3H] arginine uptake into rat cerebellar synaptosomes: kinetics and pharmacology. J. Neurochem. 67, 1275-1281.
26. Rao V. L. R. and Murthy C. R. K. (1991) Hyperammonemic alterations in the uptake and release of glutamate and aspartate by rat cerebellar preparations. Neurosci. Lett. 130, 49-52.
27. Rao V. L. R. and Murthy C. R. K. (1992) Ammonia-induced alterations in the metabolism of glutamate and aspartate in neuronal perikarya and synaptosomes of rat cerebellum. Metab. Brain Dis. 7, 51-61.
28. Rao V. L. R., Agrawal A. K., and Murthy C. R. K. (1991) Ammonia-induced alterations in glutamate and muscimol binding to cerebellar synaptic membranes. Neurosci. Lett. 130, 251-254.
29. Rao V. L. R., Murthy C. R. K., and Butterworth R. F. (1992) Glutamatergic synaptic dysfunction in hyperammonemic syndromes. Metab. Brain Dis. 7, 1-20.
30. 3H] arginine uptake in brain following portacaval anastomosis. J. Neurochem. 65, 677-681.
31. Rao V. L. R., Audet R. M., and Butterworth R. F. (1995b) Selective alteration of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: results of an in vivo microdialysis study. J. Neurochem. 65, 1221-1228.
32. Rao V. L. R., Mousseau D. D., and Butterworth R. F. (1996) Nitric oxide synthase activities are selectively decreased in vulnerable brain regions in thiamine deficiency. Neurosci. Lett. 208, 1-4.
33. Schmidlin A. and Wiesinger H. (1994) Transport of L-arginine in cultured glial cells. Glia 11, 262-268.
34. Schmidt K., List B. M., Klatt P., and Mayer B. (1995) Characterization of neuronal amino acid transporters: uptake of nitric oxide synthase inhibitors and implications for their biological effects. J. Neurochem. 64, 1469-1475.
35. Shinya H., Matsuo N., Takeyama N., and Tanaka T. (1996) Hyperammonemia inhibits platelet aggregation in rats. Thromb. Res. 81, 195-201.
36. +) of the rat blood-brain barrier. J. Neurochem. 60, 1956-1959.
37. Stuhlmiller D. F. E. and Boje K. M. K. (1995) Characterization of L-arginine and aminoguanidine uptake into isolated rat choroid plexus: differences in uptake mechanisms and inhibition by nitric oxide synthase inhibitors. J. Neurochem. 65, 68-74.
38. Tossman U., Eriksson S., Delin A., Hagenfeldt L., Law D., and Ungerstedt U. (1983) Brain amino acids measured by intracerebral dialysis in portacaval shunted rats. J. Neurochem. 41, 1046-1051.
39. 3H]arginine in cultured neurons: characteristics and inhibition by nitric oxide synthase inhibitors. J Neurochem. 61, 364-367.
40. Wu W., Liuzzi F. J., Schinco F. P., Depto A. S., Li Y., Mong J. A., Dawson T. M., and Snyder S. H. (1994) Neuronal nitric oxide synthase is induced in spinal neurons by traumatic injury. Neuroscience 61, 719-726.
41. Zhang F., Xu S., and Iadecola C. (1995) Time dependence of effects of nitric oxide synthase inhibition on cerebral ischemic damage. J. Cereb. Blood Flow Metab. 15, 595-601.